Search results for "bladder neoplasm"

showing 10 items of 158 documents

Sarcomatoid carcinoma of urinary bladder: Immunohistochemical study of an uncommon case

2002

A case of sarcomatoid carcinoma of the bladder is reported herein. Immunohistochemical staining with human pancytokeratin antibody was negative, while vimentin staining was strongly positive, suggesting a diagnosis of sarcoma of the bladder. Further immunohistochemical analysis revealed positivity for AE1/AE3 cytokeratins, permitting a correct diagnosis of sarcomatoid carcinoma of the bladder. It can be difficult to distinguish between sarcomatoid carcinoma, undifferentiated carcinoma and sarcoma, particularly if the biopsy specimens are of small size. In rare cases, sarcomatoid tumors may express epithelial markers different from those revealed by human pancytokeratin staining. Copyright ©…

Pathologymedicine.medical_specialtyUrinary bladder tumorAE1/AE3 cytokeratinmedicine.medical_treatmentUrologyVimentinSarcomatoid carcinomaCystectomyCytokeratinBiopsyHumansMedicineSarcomatoid carcinomaAgedUrinary bladderbiologymedicine.diagnostic_testAE1/AE3 cytokeratins; Human pancytokeratin; Sarcomatoid carcinoma; Urinary bladder tumors; Urologybusiness.industryCarcinomaSarcomamedicine.diseaseImmunohistochemistrymedicine.anatomical_structureUrinary Bladder NeoplasmsHuman pancytokeratinbiology.proteinKeratinsFemaleSarcomabusinessSpindle cell carcinoma
researchProduct

Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors

2012

Purpose: Women undergoing radical cystectomy (RC) and urinary diversion for bladder cancer experience substantial limitations in health-related quality of life (HRQOL). However, the level of discomfort caused by different urinary diversion has been never evaluated in long term survivors. The aim of this multicenter study is to evaluate differences in HRQOL among recurrence-free women undergoing cutaneous ureterostomy (CUS), Bricker's ileal conduit (BK-IC) and Orthotopic neobladder VIP (ONB-VIP) in disease-free females treated with radical cystectomy (RC), with long-term follow up (mean 60.1 months; range 36-122 months). Materials and methods: All consecutively treated female patients from t…

Quality of lifemedicine.medical_specialtyTime FactorsTime Factormedicine.medical_treatmentUrologyDisease freeUrinary DiversionCystectomyUreterostomyCystectomyQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansSurveys and QuestionnaireSurvivorsOrthotopic urinary reservoirUreterostomyAgedAged 80 and overBladder cancerbusiness.industryResearchBladder cancerUrinary Reservoirs ContinentUrinary diversionPublic Health Environmental and Occupational HealthCancerOrthotopic urinary reservoirsGeneral MedicineMiddle Agedmedicine.diseasehumanitiesUrinary Bladder Neoplasmsradical cystectomy; Quality of lifeMulticenter studyBladder cancer; Orthotopic urinary reservoirs; Quality of life; Urinary diversionUrinary Bladder NeoplasmFemaleSurvivorbusinessUrinary diversion; Orthotopic urinary reservoirs; Bladder cancer; Quality of lifeHumanHealth and Quality of Life Outcomes
researchProduct

The pathology of bladder cancer: An update on selected issues

2006

OBJECTIVE: To achieve a closer relationship between urologists and pathologists and to use a common language and identical objectives in the pathology of bladder cancer. METHODS AND RESULTS: Special emphasis was given to an analysis of the new World Health Organization (WHO) grading system, to the interpretation of the last Tumour-Nodes-Metastasis staging rules, and to identifying new markers of prognostic significance in clinical practice. A consensus was achieved on the main points. CONCLUSIONS: The 2004 WHO grading system must become acceptable to clinicians, perhaps by a minimal modification of the present terminology. Simple transurethral resection-biopsy should be expressed in terms o…

Stage classificationWorld Health Organization (WHO) grading systemPathologymedicine.medical_specialtyBladder cancerbusiness.industryUrologyPathological stagingBiopsy NeedleAnatomical pathologytransurethral resection-biopsyPrognosismedicine.diseaseWorld healthTerminologyClinical PracticeUrinary Bladder NeoplasmsBiomarkers TumormedicineHumansGrading (education)businessNeoplasm Staging
researchProduct

Intraductal aspiration: a promising new tissue-sampling technique for the diagnosis of suspected malignant biliary strictures

2012

Brushing is the most commonly used technique for biliary sampling at ERCP, despite its limited sensitivity. To evaluate intraductal aspiration (IDA) as a new combined endoscopic technique for cytodiagnosis, its cellular adequacy, diagnostic accuracy for cancer detection, feasibility, and safety. Prospective, observational study. Single tertiary referral center. IDA cellular adequacy, diagnostic accuracy for cancer detection, feasibility, and safety. From April 2009 to September 2010, 42 consecutive patients with suspected malignant biliary stricture underwent ERCP, with tissue sampling obtained with IDA. IDA included performance of standard brushing in all patients. After standard brushing,…

Suction (medicine)AdultMalemedicine.medical_specialtyCytodiagnosisConstriction PathologicCholangiocarcinomaPredictive Value of Testshemic and lymphatic diseasesBiopsymedicineHumansRadiology Nuclear Medicine and imagingSampling (medicine)Prospective StudiesProspective cohort studydiagnosis of suspected malignant biliary strictureIntraductal aspirationAgedAged 80 and overCholangiopancreatography Endoscopic RetrogradeCholestasisReceiver operating characteristicmedicine.diagnostic_testbusiness.industryBiopsy NeedleGastroenterologyTissue samplingMiddle AgedSurgeryCatheterBile Duct NeoplasmsPredictive value of testsFemaleGallbladder NeoplasmsRadiologyBile Ductsbusiness
researchProduct

Preliminary Results of ERAS Protocol in a Single Surgeon Prospective Case Series

2022

Background and Objectives: The aim was to compare the intra and postoperative outcomes between the Enhanced Recovery After Surgery (ERAS) protocol versus the standard of care protocol (SCP) in patients who underwent radical cystectomy performed by a single surgeon. Materials and Methods: A retrospective comparative study was conducted including patients who underwent radical cystectomy from 2017 to 2020. Length of stay (LOS), incidence of ileus, early postoperative complications, and number of re-hospitalizations within 30 days were considered as primary comparative outcomes of the study. Results: Data were collected for 91 patients who underwent cystectomy, and 70 and 21 patients followed …

SurgeonsGeneral MedicineLength of StayCystectomyoutcomesPostoperative ComplicationsUrinary Bladder Neoplasmsenhanced recovery after surgeryHumansbladder cancerERASenhanced recovery after surgery; outcomes; ERAS; radical cystectomy; bladder cancerradical cystectomyAgedRetrospective Studies
researchProduct

Urinary Diversion: How Experts Divert

2014

To determine the rates of the available urinary diversion options for patients treated with radical cystectomy for bladder cancer in different settings (pioneering institutions, leading urologic oncology centers, and population based).Population-based data from the literature included all patients (n = 7608) treated in Sweden during the period 1964-2008, from Germany (n = 14,200) for the years 2008 and 2011, US patients (identified from National Inpatient Sample during 1998-2005, 35,370 patients and 2001-2008, 55,187 patients), and from Medicare (n = 22,600) for the years 1992, 1995, 1998, and 2001. After the International Consultation on Urologic Diseases-European Association of Urology In…

Swedenmedicine.medical_specialtyBladder cancerbusiness.industryUrologymedicine.medical_treatmentUrinary diversionUrologyUrologic OncologyPopulation basedUrinary DiversionCystectomymedicine.diseaseUnited StatesCystectomyUrinary Bladder NeoplasmsGermanymedicineHumansPractice Patterns Physicians'businesshuman activitiesUrology
researchProduct

Histophotometry: a new method for automated histological examination of solid tissue samples demonstrated on bladder cancer.

1979

The purpose of this study was to demonstrate the ability of a new method to discriminate between benign and malignant tissue. Tissue samples from three patients with bladder tumours and one patient with bladder diverticula have been examined by histophotometry. This method, based on the correlation of nuclear volume and nucleic acid contents per cell uses thick formalin fixed samples. The results are obtained by measurements averaging more than one hundred thousand cells per sample. By this histophotometric examination a clear differentiation between malignant and benign tissue could be achieved. It was also possible to determine the degree of malignancy and to differentiate between infiltr…

Thousand cellsPathologymedicine.medical_specialtyBladder cancerUrologyHistological TechniquesHistologyFormalin fixedBiologyIn Vitro TechniquesMalignancymedicine.diseaseSolid tissuePhotometryBladder TissueUrinary Bladder NeoplasmsmedicineHumansHistological examinationUrological research
researchProduct

The Role of Novel Bladder Cancer Diagnostic and Surveillance Biomarkers—What Should a Urologist Really Know?

2022

The aim of this review is to analyze and describe the current landscape of bladder cancer diagnostic and surveillance biomarkers. We researched the literature from 2016 to November 2021 to find the most promising new molecules and divided them into seven different subgroups based on their function and location in the cell. Although cystoscopy and cytology are still the gold standard for diagnosis and surveillance when it comes to bladder cancer (BCa), their cost is quite a burden for national health systems worldwide. Currently, the research is focused on finding a biomarker that has high negative predictive value (NPV) and can exclude with a certainty the presence of the tumor, considering…

Urinary Bladder NeoplasmsdiagnosisPredictive Value of TestsUrologistsHealth Toxicology and MutagenesissurveillanceBiomarkers TumorPublic Health Environmental and Occupational Healthbiomarkersbladder cancerHumansCystoscopyInternational Journal of Environmental Research and Public Health
researchProduct

VESICAL IMAGING-REPORTING AND DATA SYSTEM – A NEW APPROACH TO BLADDER CANCER STAGING

2022

The aim: To present the assumptions and to show the usefulness of Vesical Imaging-Reporting and Data System (VI-RADS) based on multiparametric magnetic resonance imaging (mpMRI) in the diagnostic pathway management of patients with a bladder cancer. Materials and methods: The review is based on available literature from last 10 years from PubMed database and the Przegląd Urologiczny journal focusing on articles on VI-RADS. Overall, 18 articles were included. Presented magnetic resonance images come from the examinations of the patients who were diagnosed with bladder cancer from 2019 to 2021 at Department of Diagnostic Imaging in University Clinical Hospital in Opole, Poland. Conclusions: T…

Urinary Bladder Neoplasmsreference standardsUrinary BladderData SystemsHumansdiffusion-weighted magnetic resonance imagingProspective StudiesGeneral Medicinemultiparametric magnetic resonance imagingMagnetic Resonance ImagingNeoplasm StagingWiadomości Lekarskie
researchProduct

Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours

2008

Aims:  To correlate the immunohistochemical detection of WWOX with histological measures and disease progression within the whole spectrum of urothelial bladder neoplasms. Methods and results:  One hundred and one patients with primary bladder tumours were retrospectively analysed. Immunohistochemically, a polyclonal antibody was utilized and the level of WWOX protein expression was analysed by using a combined score system based on intensity of the reaction and percentage of immunoreactive tumour cells. WWOX protein expression was consistently expressed in non-neoplastic urothelium, whereas a progressive loss of immunoreactivity was observed as tumour grade and stage increased (P < 0.05). …

WWOXAdultMalePathologymedicine.medical_specialtyHistologyCell CountBiologyArticlePathology and Forensic MedicinemedicineCarcinomaBiomarkers TumorHumansSurvival rateAgedRetrospective StudiesAged 80 and overCarcinoma Transitional CellPredictive markerUrinary bladderTumor Suppressor ProteinsCancerGeneral MedicineMiddle Agedmedicine.diseaseSquamous metaplasiaSurvival Ratemedicine.anatomical_structureUrinary Bladder NeoplasmsWW Domain-Containing OxidoreductaseSpainFemaleUrotheliumOxidoreductasesProgressive disease
researchProduct